SecBot SecBot
PRESS-RELEASE ·Filed May 21, 2026

MDLN

Medline Inc.
BEARISH
Impact 6/10
Horizondays Processed5mo ago WireGlobeNewswire
Press release · Offering
Actionable Insight ▼ Bearish

Massive secondary block sale by PE sponsors creates near-term supply overhang, expect price pressure on MDLN common shares as the market absorbs the ~3.3% float increase (the greenshoe adds ~0.5%). Watch the first few trading days post-close (May 28) for the underwriters to stabilize; heavy volume relative to ADV is a bearish sign. No company cash infusion means no fundamental improvement to offset dilution.

DirectionBearish
Confidencehigh
Horizondays

How the stock moved after the report

⚠ Clustered BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$37.01
T+0 close · May 21, 2026 · via day close
Latest settled
−7.81%
T+60 · $34.12
Vs SPY
−11.00%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 22 $37.01entry
  2. T+1 · 6mo ago −2.30%α −2.88% · $36.16
  3. T+5 · 6mo ago −3.40%α −5.06% · $35.75
  4. T+20 · 5mo ago −4.59%α −3.18% · $35.31
  5. T+60 · 3mo ago −7.81%α −11.00% · $34.12

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Medline's PE owners (Blackstone, Hellman & Friedman, ADIA) priced a 72.6M-share secondary offering at $37.00/share, raising ~$2.68B in proceeds that go entirely to the selling stockholders, Medline receives none. The offering is ~3.3% of shares outstanding (assuming ~2.2B fully diluted) and underwriters have a 30-day option for an additional 10.9M shares. Secondary block sales by controlling shareholders signal a monetization event and create near-term overhang, though the company itself gets no cash.

Key Financial Metrics

Deal Value
$2.7T

Key Facts

  • Secondary offering of 72,554,594 shares priced at $37.00 per share
  • Selling stockholders include affiliates of Blackstone, Hellman & Friedman, and Abu Dhabi Investment Authority
  • Medline receives no proceeds from the offering
  • Underwriters granted 30-day option to purchase up to an additional 10,883,189 shares
  • Expected closing date is May 28, 2026
  • Goldman Sachs, Morgan Stanley, BofA Securities, J.P. Morgan are global coordinators
  • Total proceeds to selling stockholders ~$2.68B base; up to ~$3.09B if greenshoe fully exercised

Financial Impact

~$2.68 billion in proceeds to selling stockholders from 72.6M shares at $37.00; potential additional ~$403M if greenshoe exercised

dilutionshare supply

Risk Factors

  • Further secondary sales by PE owners if lockup expires
  • Greenshoe exercise adds ~$403M more supply
  • No company use of proceeds, signals PE exit, not growth investment
  • Overhang may persist until the Street absorbs the full block

Market Snapshot

Exchange
Nasdaq
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
79% bullish (34 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3299874

Track record

30 reports on MDLN

Performance horizon

4 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +17.95% at T+20 after the May 6, 2026 report. 4 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today Press Release Bearish 5/10 Entry $36.40 Now $39.17 −7.61% settles Nov 23
  2. Nov 16, 2026today S-1 Neutral 4/10 Entry price pending
  3. Nov 13, 20263d ago SC 13G Neutral 3/10 Entry $42.00 Now $39.17 −6.74% settles Nov 23
  4. Nov 13, 20263d ago 144 Neutral 2/10 Entry $42.00 Now $39.17 −6.74% settles Nov 23
  5. Nov 6, 202610d ago SC 13G/A Neutral 3/10 Entry $40.71 to $39.17 Now $39.17 −3.78% ▼ −3.78% −2.09% vs SPY
  6. Nov 4, 202612d ago 8-K Neutral 5/10 No price data
  7. Nov 4, 202612d ago Press Release Bullish 6/10 Entry $40.35 to $42.16 Now $39.17 −2.92% ▲ +4.49% +5.40% vs SPY
  8. Nov 2, 202614d ago Institutional Cluster Bearish 4/10 Entry $34.09 to $40.91 Now $39.17 −14.90% ▼ −20.01% −20.59% vs SPY
  9. Oct 30, 202617d ago SC 13G/A Neutral 3/10 Entry $32.12 to $39.64 Now $39.17 +21.95% ▲ +23.41% +26.12% vs SPY
  10. Oct 21, 202626d ago 8-K Bearish 6/10 Entry $34.88 to $32.00 Now $39.17 −12.30% ▲ +8.26% +8.96% vs SPY
Showing 10 of 30

US Market Status

Market Closed · Opens Wed (11h 54m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 21, 2026